On September 26, State Grid Huai'an Power Supply Company sent a team of technical experts to Jiangsu Xiuzheng Pharmaceutical Group Co., Ltd. to conduct a safety inspection of electricity use, ensuring safe and reliable power supply during the holiday period.
Providing Professional Power Safety Services
The Phase I project of Jiangsu Xiuzheng Pharmaceutical is a provincial-level key project in Jiangsu's biotechnology and new pharmaceutical sector, with construction commencing in March 2023. On October 30, 2024, the company submitted an application for a new 6,800 kVA high-voltage power supply.
In response, State Grid Huai'an Power Supply Company immediately activated its major project power supply guarantee mechanism. Customer managers and technical experts jointly conducted multiple on-site surveys, using the "One-Map Grid" system to accurately analyze surrounding load and grid planning. Based on these findings, the company designed an optimal power access plan, placing the connection point just 170 meters from the enterprise's distribution room. This "doorstep connection" not only significantly reduced investment costs for the enterprise but also enhanced the efficient integration of regional grid resources.
Jiangsu Xiuzheng Pharmaceutical is engaged in extraction, preparation, quality inspection, and other processes, all of which place high demands on power quality. Its purification and air-conditioning systems in particular require stable, 24-hour operation. To ensure reliability, State Grid Huai'an Power Supply Company established a professional team to provide full-process guidance in the construction of the company's power facilities. Taking into account the enterprise's actual load characteristics and strict power quality requirements, the team helped minimize voltage fluctuations at the source, building a solid "power shield" for safe pharmaceutical production.
"The power company responded swiftly with tailored solutions. Even after operations began, they continue to provide regular on-site services, helping us resolve power concerns and saving us time, effort, and costs," said Yu Wenbin, a representative of Jiangsu Xiuzheng Pharmaceutical Group Co., Ltd. (By Zhi Linyue Wang Jiahui)